Loading clinical trials...

A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease | Clinical Trials | Clareo Health

COMPLETEDNCT04312659

A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease

The main purpose of this study is to record the use of Infliximab (IFX) in the treatment of Chinese children with Crohn's disease (CD) in routine clinical practice and to summarize the clinical effica...

Lead sponsor: Johnson & Johnson (China) Investment Ltd.•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Decoding the Clinical Impact of Host and Microbial Intestinal Proteomic Landscape in Crohn's Disease

NCT06494826 · Crohn Disease

RECRUITINGPhase 4

Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease

NCT07292012 · Crohn Disease (CD)

RECRUITINGPhase 3

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

NCT06651281 · Crohn Disease, Colitis, Ulcerative

RECRUITING

Immunological Characteristics of Preclinical IBD

NCT05698745 · Crohn Disease, Ulcerative Colitis, and more

RECRUITINGNA

Early vs Delayed Surgery for Stricturing CD--a RCT

NCT05421455 · Crohn Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 27, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment38

Start dateJul 2020

Last updatedApr 27, 2025

Condition

Crohn Disease

Locations shown

Guangzhou Women And Children's Medical Center

Guangzhou

The Childrens Hospital Zhejiang University School Of Medicine

Hangzhou

Ruijin Hospital Shanghai Jiao Tong University

Shanghai

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 27, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions